Cogent Biosciences, Inc.
COGTNASDAQHealthcare● Active
$31.16
+$0.14(+0.45%)
Market Cap$5.3B
P/E Ratio—
52W High$43.73
52W Low$5.485
Cogent Biosciences, Inc.（COGT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · COGT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.27B | $0.23B | $0.17B | $0.12B | $0.06B |
| G&A Expenses | $0.06B | $0.04B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.33B | $0.28B | $0.21B | $0.15B | $0.08B |
| Operating Income | ($0.33B) | ($0.28B) | ($0.21B) | ($0.15B) | ($0.08B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.33B) | ($0.26B) | ($0.19B) | ($0.14B) | ($0.07B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.33B) | ($0.26B) | ($0.19B) | ($0.14B) | ($0.07B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.55 | $-2.46 | $-2.42 | $-2.26 | $-1.85 |
| Wtd Avg Shares | 0.07B | 0.10B | 0.08B | 0.06B | 0.04B |
| EBITDA | ($0.33B) | ($0.27B) | ($0.20B) | ($0.14B) | ($0.07B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Cogent Biosciences, Inc.
关于Cogent Biosciences, Inc.（COGT）损益表
Cogent Biosciences, Inc.（COGT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，COGT实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.33B)（净利率—）。
常见问题
COGT · 4 问Cogent Biosciences, Inc.（COGT）2025财年营收为$0.00B，同比down—%。
COGT revenueCOGT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08